Online interpretation training to reduce pain in people with Type 2 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with Type 2 diabetes and persistent pain are assigned to either a cognitive bias modification for interpretation (CBM-I) program or a placebo/comparator delivered online. The active program involves four ~30-minute sessions that present ambiguous scenarios resolved in benign ways to train less pain-focused interpretations. Interpretation bias is measured after the fourth session, and pain severity and interference (alongside mood, quality of life, and related measures) are collected at baseline, post-training, two-week, and three-month follow-ups. Eligibility requires age ≥18, a diagnosis of Type 2 diabetes, persistent pain for ≥3 months, average BPI pain severity ≥3, English fluency, and internet/computer access.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Over 18 years of age
* Have a diagnosis of Type 2 diabetes.
* Have persistent pain (pain present on more days than not, for 3 months or longer).
* Score ≥ 3 on average pain severity on the Brief Pain Inventory (BPI).
* Fluent in English
* Have access to internet and ability to use a computer over a three month period.

Exclusion Criteria:

* Under 18 years of age
* No diagnosis of Type 2 diabetes
* No persistent pain
* Not fluent in English
* No access to internet nor ability to use a computer.

Where it's running

• University of Sydney
  Camperdown, New South Wales, Australia Recruiting

Study contacts

• Principal investigator: Louise Sharpe — University of Sydney
• Study coordinator: Tessa Rooney
• Email: tessa.rooney@sydney.edu.au
• Phone: +61449610131

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Acute Blood Flow Restriction Walking in Type 2 Diabetes

  This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.

  Recruiting University of British Columbia · Kelowna, British Columbia · NCT07928531

• Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin

  This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.

  Recruiting Medical University of Bialystok · Bialystok · NCT07919236

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses

  This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.

  Recruiting at 2 sites German Institute of Human Nutrition · Berlin and 1 other locations · NCT07888257

• Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar

  This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.

  Recruiting German Institute of Human Nutrition · Potsdam, Potsdam-Rehbrücke · NCT07868601

• Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes

  This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.

  Recruiting at 2 sites Phase 1 Novo Nordisk A/S · Glendale, California and 1 other locations · NCT07868354

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.